News
If you're a journalist with a media enquiry, please contact the Pfizer UK press office.
Please note that this route is intended for journalists with specific enquiries. We are unable to respond to any non-media enquiries submitted via this route.
Tel: 0845 300 8033
Email: pressofficeUK@pfizer.com
PP-PFE-GBR-2513 / April 2020
-
Recognising the signs and symptoms of blood cancer this September16/09/20 -
Biopharma Leaders Unite To Stand With Science09/09/20 -
Get the Facts on Our COVID-19 Vaccine Candidates07/08/20 -
Pfizer Pledges $100 Million to New Industry Fund to Help Fight Growing Threat of Antimicrobial Resistance13/07/20 -
Pfizer and Wellcome Launch Surveillance Programme to Combat Growing Threat of Antimicrobial Resistance in Sub-Saharan Africa07/07/20 -
And the winners are…‘Superbugs: Join the Fight’ school competition finalists announced07/07/20 -
Even Superheroes need a Sidekick29/06/20 -
Pfizer Establishes New Programme to Support Continued Biotechnology Innovation12/06/20 -
ByYourSide app and website launched to help cancer patients in need03/06/20 -
Pfizer and BioNTech Start Human Trials as Part of Global COVID-19 Vaccine Development Programme14/05/20 -
Inspiring the UK’s next generation of scientists from home13/05/20 -
The power of our people11/05/20 -
Pfizer expands home learning resources with 'Science in a Box'30/04/20 -
Pfizer's 'Superbugs: Join the fight' educational resources now available for home-learning30/04/20 -
World Immunisation Week: The importance of maintaining routine immunisations29/04/20 -
Pfizer Advances Battle Against COVID-19 on Multiple Fronts09/04/20